FDA Panel Votes in Favor of Weight Loss Drug Qnexa

FDA Panel Votes in Favor of Weight Loss Drug Qnexa
An FDA advisory panel has voted 20-2 to recommend approval of the weight-loss drug Qnexa, but urged the agency to require a post-approval trial to monitor for cardiovascular side effects.